Cargando…
Emerging evidence for CHFR as a cancer biomarker: from tumor biology to precision medicine
Novel insights in the biology of cancer have switched the paradigm of a “one-size-fits-all” cancer treatment to an individualized biology-driven treatment approach. In recent years, a diversity of biomarkers and targeted therapies has been discovered. Although these examples accentuate the promise o...
Autores principales: | Derks, Sarah, Cleven, Arjen H. G., Melotte, Veerle, Smits, Kim M., Brandes, Johann C., Azad, Nilofer, van Criekinge, Wim, de Bruïne, Adriaan P., Herman, James G., van Engeland, Manon |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2013
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3988518/ https://www.ncbi.nlm.nih.gov/pubmed/24375389 http://dx.doi.org/10.1007/s10555-013-9462-4 |
Ejemplares similares
-
Stromal Expression of Hypoxia Regulated Proteins Is an Adverse Prognostic Factor in Colorectal Carcinomas
por: Cleven, Arjen H. G., et al.
Publicado: (2007) -
The emerging role of GATA transcription factors in development and disease
por: Lentjes, Marjolein HFM, et al.
Publicado: (2016) -
Technical considerations in PCR-based assay design for diagnostic DNA methylation cancer biomarkers
por: Massen, Maartje, et al.
Publicado: (2022) -
Current state-of-the-art on ganglioside-mediated immune modulation in the tumor microenvironment
por: van der Haar Àvila, Irene, et al.
Publicado: (2023) -
Secreted frizzled-related protein 2: a key player in noncanonical Wnt signaling and tumor angiogenesis
por: van Loon, Karlijn, et al.
Publicado: (2020)